TL
Tilray Brands, Inc.
TLRY.TO · TSX
$5.56 -2.97% (-$0.17)
1M -10.47%
Market Cap $448.4M
P/E Ratio -
Div. Yield -
ROE 8.85%
Piotroski F-Score Weak
3/9Valuation
44 /100
Fair EV/EBITDA 35.35x
P/B 0.28x
P/S 0.49x
Growth
62 /100
Stable Rev. growth 13.16%
Book val. growth 21.37%
EPS growth N/A
Profitability
10 /100
Weak Gross margin 27.77%
FCF margin 11.97%
Net margin 15.22%
Quality
5 /100
Poor ROIC 3.29%
Asset turnover 0.39x
ROE 8.85%
Debt
45 /100
Moderate Debt/Equity 0.25x
Net debt/EBITDA 9.67x
Current ratio 2.21x
Stability
27 /100
Unstable Beta 1.92x
Profitable years 0
Rev. volatility 10.64%
Bulios Scoring opisuje kakovost in preteklost podjetja, ne prihodnjega donosa. Visok rezultat ni nakupni signal. Izvedite več
Vprašajte StockBota o TLRY.TO
Online
Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic
CEO
Irwin David Simon
Employees
3,595
Headquarters
Leamington
Prihajajoči dogodki
08 OKT.
Earnings
Upcoming earnings report